MorphoSys's Licensing Partner GSK Shared Preliminary Results From OSCAR Study with Otilimab for the Treatment of Severe Pulmonary COVID-19 Related Disease; Expanding the Study for Patients 70 Years and Older

March 2, 2021 4:01 PM

PLANEGG/MUNICH, GERMANY / ACCESSWIRE / March 2, 2021 / MorphoSys AG (FSE:MOR; Prime Standard Segment; MDAX & TecDAX; NASDAQ:MOR), a commercial-stage biopharmaceutical company and a leader in antibody, protein and peptide technologies, announced today that its licensing partner GlaxoSmithKline plc (LSE/NYSE: GSK) reported preliminary results of the OSCAR (Otilimab in Severe COVID-19 Related Disease) study using otilimab (formerly...

Read more

Citizen Stash Expands Its Product Line by 44% in Ontario, Canada’s Largest Cannabis Market

March 2, 2021 8:45 AM

VANCOUVER, BC / ACCESSWIRE / March 2, 2021 / Experion Holdings Ltd. (the "Company" or "Experion") (TSXV:EXP)(OTCQB:EXPFF)(FRANKFURT:MB31) Canada's solution to craft cannabis supply and builder of premium cannabis brands including its sought after and popular Citizen Stash brand, is pleased to announce a 44% increase of its premium product line up with the Ontario Cannabis Store (OCS) bringing its total registered product...

Read more

Nascent Biotech Earns US Patent for Crossing Blood-Brain Barrier

March 2, 2021 8:00 AM

SAN DIEGO, CA / ACCESSWIRE / March 2, 2021 / Nascent Biotech, Inc. (OTCQB:NBIO) ("Nascent Biotech", "Nascent", or the "Company"), a clinical-stage biotechnology Company pioneering the development of monoclonal antibodies targeting treatment of various cancers and viral infections, is excited to announce that the Company has officially received allowance for a "Method-of-Use" patent by the US Patent and...

Read more

Apollo Endosurgery Receives FDA Breakthrough Device Designation for the Orbera(R) Intragastric Balloon for Treatment of Patients with NASH

March 1, 2021 6:30 AM

AUSTIN, TX / ACCESSWIRE / March 1, 2021 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in minimally invasive medical devices for gastrointestinal and bariatric procedures, announced today that it has received a Breakthrough Device Designation from the U.S. Food and Drug Administration for the Orbera® Intragastric Balloon, specifically for the indication for use in treating patients with BMI between 30-40...

Read more

Molecular Partners Publishes Audited Financial Results for 2020 and Annual Report 2020

February 26, 2021 1:00 AM

ZURICH-SCHLIEREN, SWITZERLAND / ACCESSWIRE / February 26, 2021 / Molecular Partners AG (SIX:MOLN), a clinical-stage biotech company developing a new class of custom-built protein drugs known as DARPin® therapeutics, today published its audited Financial Results for 2020 and the company's 2020 Annual Report. The Audited Financial Results for 2020 and the company's 2020 Annual Report are available on the investors section of the...

Read more

Edesa Biotech Increases Previously Announced Bought Deal Offering of Common Shares to $10.0 Million

February 25, 2021 10:20 PM

TORONTO, ON / ACCESSWIRE / February 25, 2021 / Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on inflammatory and immune-related diseases, today announced that, due to demand, the underwriter has agreed to increase the size of the previously announced public offering and purchase on a firm commitment basis 1,562,500 common shares of Edesa, at a price to the public of $6.40 per share, less underwriting...

Read more

Edesa Biotech Announces $3.5 Million Bought Deal Offering of Common Shares

February 25, 2021 5:12 PM

TORONTO, ON / ACCESSWIRE / February 25, 2021 / Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on inflammatory and immune-related diseases, today announced that it has entered into an underwriting agreement with H.C. Wainwright & Co., LLC under which the underwriter has agreed to purchase on a firm commitment basis 546,875 common shares of Edesa, at a price to the public of $6.40 per share, less...

Read more

Apollo Endosurgery, Inc. Reports Fourth Quarter and Full Year 2020 Results

February 25, 2021 4:01 PM

Conference Call to Discuss Results Today at 3:30 p.m. CT / 4:30 p.m. ET AUSTIN, TX / ACCESSWIRE / February 25, 2021 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, today announced financial results for the fourth quarter and year ended December 31, 2020. The Company will hold a conference call today at 3:30 p.m. CT / 4:30 p.m. ET to...

Read more

Tetra Bio-Pharma To Monetize Its Dronabinol And Botanical Product Portfolios

February 25, 2021 7:00 AM

Company signs LOI for Nordics and Germany OTTAWA, ON / ACCESSWIRE / February 25, 2021 / Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX:TBP)(OTCQB:TBPMF), a biopharmaceutical pioneer in immunomodulator drug discovery and development announced the signing of a Letter of Intent with DanCann Pharma A/S (SS: DANCAN) for the exclusive distribution of Reduvo™ Adversa® and QIXLEEF™ in Denmark,...

Read more

American CryoStem and BioTherapeutic Labs Corp. Enter into R&D, Collaboration and Marketing Agreement

February 25, 2021 1:00 AM

EATONTOWN, NJ / ACCESSWIRE / February 25, 2021 / American CryoStem Corporation (OTC PINK:CRYO), a clinical stage biotechnology company, global licensor and a pioneer in autologous cellular processing and therapies, announced today that it has entered into an Agreement with BioTherapeutic Labs Corp. (BTL) an FDA registered Umbilical Cord Tissue Manufacturing Company headquartered in Boca Raton, Florida. CRYO will optimize cell recovery from...

Read more

First U.S. Patent Allowed on Hancock Jaffe VenoValve

February 24, 2021 12:05 PM

Company Receives Notice of Allowance from U.S. Patent and Trademark Office IRVINE, CA / ACCESSWIRE / February 24, 2021 / Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI), a developer of medical devices that restore cardiac and vascular health, today announced that it has received a notice of allowance from the United States Patent and Trademark Office (USPTO) for a patent covering the company's VenoValve. The patent, which focuses on novel...

Read more

Citizen Stash Cannabis Edibles Enters Largest Canadian Market

February 24, 2021 8:45 AM

VANCOUVER, BC / ACCESSWIRE / February 24, 2021 / Experion Holdings Ltd. (the "Corporation" or "Experion") (TSXV:EXP)(OTCQB:EXPFF)(FRANKFURT:MB31) Canada's solution to craft cannabis supply and builder of premium cannabis brands including its sought after and popular brand Citizen Stash, announced today the launch of it's edible 5mg gummy into the Ontario Market. Designed for the legal adult recreational market,...

Read more

MJ Biotech Offers Covid-19 FDA Approved Nasopharyngeal Specimen Collection Swabs RT-PCR COVID Test Kit

February 24, 2021 7:02 AM

CHEYENNE, WY / ACCESSWIRE / February 24, 2021 / MJ Biotech, Inc. (OTC PINK:MJTV), is pleased to report that Sterile and individually wrapped FDA approved nasopharyngeal (nasal) specimen collection swabs for the RT-PCR COVID test was added to the COVID -19 product line. This Covid-19 test (inclusive of the swabs to the RT-PCR test) is in addition to the Covid-19 IgG/IgM Antibody Rapid Test Kits already being offered by MJ Biotech, Inc. Sales...

Read more

Pieris Pharmaceuticals to Participate in the Cowen 41st Annual Health Care Conference

February 23, 2021 8:00 AM

BOSTON, MA / ACCESSWIRE / February 23, 2021 / Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS), a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin® technology platform for respiratory diseases, cancer, and other indications, today announced that Stephen S. Yoder, President and Chief Executive Officer of Pieris, is scheduled to participate in a GI Oncology and Pancreatic Cancer panel discussion...

Read more

CB Scientific, Inc. Announces Definitive Agreement to Acquire Cardiolink Corporation, an Independent Diagnostic Testing Facility (IDTF)

February 23, 2021 7:30 AM

Addition of IDTF operation has CBSC well-positioned to significantly impact the US Remote Patient Monitoring market. ESCONDIDO, CA / ACCESSWIRE / February 23, 2021 / CB Scientific, Inc. (OTC PINK:CBSC) ("CBSC" or the "Company"), in an ongoing effort to expand its outreach in the Ambulatory Remote Cardiac Diagnostic Monitoring Services market in the United States, is pleased to announce a definitive purchase agreement...

Read more

Apollo Endosurgery to Report Fourth Quarter and Full Year 2020 Financial Results on February 25, 2021

February 22, 2021 4:30 PM

AUSTIN, TX / ACCESSWIRE / February 22, 2021 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in next-generation minimally invasive medical devices for gastrointestinal and bariatric procedures, today announced that the Company is scheduled to release its financial results for the fourth quarter and full year ended December 31, 2020 on Thursday, February 25, 2021 after the market closes. In conjunction with the...

Read more

Molecular Partners to Present at Upcoming Healthcare Investor Conferences

February 22, 2021 11:40 AM

ZURICH-SCHLIEREN, SWITZERLAND / ACCESSWIRE / February 22, 2021 / Molecular Partners AG (SIX:MOLN), a clinical-stage biotech company developing a new class of custom-built protein drugs known as DARPin® therapeutics, today announced that its Chief Executive Officer, Patrick Amstutz, Ph.D., will present at or attend several upcoming virtual healthcare investor events in February and March 2021. Conference Presentation Details: Event:...

Read more

Havn Life Announces DTC Eligibility of Its Common Shares in the United States

February 22, 2021 8:00 AM

VANCOUVER, BC / ACCESSWIRE / February 22, 2021 / Havn Life Sciences Inc. (CSE:HAVN)(OTC PINK:HAVLF)(FSE:5NP) (the "Company" or "Havn Life"), a biotechnology company pursuing standardized extraction of psychoactive compounds and the development of natural healthcare products, is pleased to announce today that its common shares are now eligible for electronic clearing and settlement through the Depository Trust Company...

Read more

MJTV Wholly Owned Subsidiary, New England Biotech Accepts Delivery Of Post Secondary CBD Extraction Lines

February 18, 2021 11:30 AM

CHEYENNE, WY / ACCESSWIRE / February 18, 2021 / MJ Biotech, Inc. (OTC PINK:MJTV), is pleased to announce its partner, Genesis Botanical Research (GBR), an MJTV Wholly Owned Subsidiary, took in the delivery of CBD extraction equipment. The post-secondary extraction lines are being erected at a temporary satellite location for assembly and fine-tuning. These lines will be moved to the Maine extraction facility once the structure is...

Read more

Viewpoint Molecular Targeting(TM) Enters into Long-Term Supply Agreement with the National Isotope Development Center of the U.S. Department of Energy Isotope Program

February 18, 2021 10:00 AM

Securing long-term supply advances development of Company's proprietary VMT-𝛼-GEN isotope generator, which enables a nimble supply of therapeutic radioisotopes with the power of alpha-particle therapy for cancer CORALVILLE, IA / ACCESSWIRE / February 18, 2021 / Viewpoint Molecular Targeting, Inc. ("Viewpoint" or the "Company"), a radiopharmaceutical company developing precision α-particle oncology therapeutics...

Read more